To view this email as a web page, click here.
 
Popular blood pressure drug recalled
A pharma maker is voluntarily recalling several lots of a major heart medication due to a carcinogenic impurity.
Read more
 
FDA approves game-changing influenza drug
While the newest influenza drug is novel, it faces stiff competition from Tamiflu and generic Tamiflu, experts say.
Read more
 
Making the right topical treatment choice in psoriasis
From our sister publication, Dermatology Times: Nearly 80% of patients experience limited-to-moderate psoriasis disease, and topical therapies account for the majority, if not all, of their treatment. But the choice of topical treatment depends on the patient.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.